文献速递主动脉疾病

开窗与分支支架修复主动脉瘤的结局:器械失败可预测再干预率

Outcome After Fenestrated and Branched Repair of Aortic Aneurysms-Device Failures Predict Reintervention Rates.
PubMed 文献 · Ann Vasc Surg · 2019-10-24

2年免于再干预率在复杂腹主动脉瘤组为75%、胸腹主动脉瘤组为35%(P=0.04);桥接支架断裂是最常见再干预原因,均见于第一代BeGraft。择期30天死亡率为1.4%,90天为2.9%。

要点

  • 桥接支架断裂是第一代BeGraft再干预主因,6例断裂均见于该支架。
  • 2年免于再干预率复杂腹主动脉瘤75%、胸腹主动脉瘤35%,差异有统计学意义。
  • 脊髓缺血是最常见主要不良事件,总发生率8.3%。

核心结论

  • 分支不稳定和再干预率较高,与第一代BeGraft桥接支架断裂明确相关。
  • 死亡率和主要不良事件发生率较低。
  • 需长期密切监测桥接支架性能,并尽早报告失败材料以避免严重并发症。

研究设计与样本

  • 共72例连续患者,其中复杂腹主动脉瘤55例、胸腹主动脉瘤17例,2例因破裂手术。
  • 共219根血管经开窗(n=163)或分支(n=56)置入支架。
  • 中位随访24个月(IQR 4-24)。

主要发现

  • 桥接支架断裂是最常见再干预原因,共6例,均位于第一代BeGraft置入血管(6/41 BeGraft vs 0/61其他支架,P<0.01)。
  • 2年免于再干预率复杂腹主动脉瘤组75%、胸腹主动脉瘤组35%(P=0.04);排除BeGraft后分别为79%和66%。
  • 最常见主要不良事件为脊髓缺血,总发生率8.3%,其中短暂性2.8%、永久性5.6%。
  • 择期30天死亡率为1.4%(1/70),90天死亡率为2.9%(2/70)。

关键数值与推荐

  • 2年免于再干预率:复杂腹主动脉瘤75%,胸腹主动脉瘤35%(P=0.04)。
  • 排除BeGraft后2年免于再干预率:复杂腹主动脉瘤79%,胸腹主动脉瘤66%。
  • 桥接支架断裂:第一代BeGraft 6/41,其他支架0/61(P<0.01)。
  • 脊髓缺血总发生率8.3%,短暂性2.8%,永久性5.6%。
  • 择期30天死亡率1.4%(1/70),90天死亡率2.9%(2/70)。

临床怎么用

  • 对使用第一代BeGraft桥接支架的F/B-EVAR患者应加强影像随访,警惕支架断裂。
  • 胸腹主动脉瘤患者再干预风险更高,需更密切监测。
  • 脊髓缺血是常见不良事件,围术期应关注脊髓保护措施。

局限性

  • 单中心回顾性设计,样本量有限(72例)。
  • 中位随访24个月,长期结果未知。
  • 第一代BeGraft已非当前主流器械,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous reports have indicated endovascular repair to be safe and effective in the treatment of complex aortic aneurysms. The endovascular technology evolves rapidly, and continuous evaluation of F/B-EVAR results is critical to detect failing techniques. Our aim was to analyze the outcome after endovascular repair of complex abdominal aortic and thoracoabdominal aneurysms. METHODS: Single-center, retrospective cohort study, of all F/B-EVAR from August 2009 to December 2018. Primary outcomes were branch instability and freedom from reinterventions at 2 years. Secondary outcomes were major adverse events and all-cause mortality at 30 and 90 days. RESULTS: A total of 72 consecutive patients were included, 55 with a complex abdominal aortic aneurysm (AAA) and 17 with a thoracoabdominal aortic aneurysm (TAAA). Two patients were operated on for rupture. A total of 219 vessels were stented through fenestrations (n = 163) or branches (n = 56). Median follow-up was 24 months (IQR 4-24). Fractured bridging stent graft was the most common cause for reintervention, n = 6. All fractures were in vessels stented with first generation BeGrafts, (6/41 BeGraft vs 0/61 other stents, P < 0.01). Freedom from reinterventions at 2 years was 75% and 35%, in the complex AAA and TAAA groups, respectively (P = 0.04) and excluding BeGrafts 79% (cAAA) and 66% (TAAA). The most common major adverse event was spinal cord ischemia (SCI), in total 8.3% with either transient (2.8%) or permanent (5.6%) deficit. Elective mortality at 30 days was 1.4% (1/70) and at 90 days was 2.9% (2/70). CONCLUSIONS: The rate of branch instability and reintervention was high, with a clear relation to fractured first-generation BeGrafts. Mortality and major adverse event rates were low. Long-term close surveillance of bridging stent graft performance is crucial, and the endovascular community should strive to find ways to report failing materials at an early stage to avoid potentially serious complications.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Lindström D, Kettunen H, Engström J, et al. Outcome After Fenestrated and Branched Repair of Aortic Aneurysms-Device Failures Predict Reintervention Rates. Ann Vasc Surg. 2019. PMID: 31669479. doi:10.1016/j.avsg.2019.10.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。